Literature DB >> 1805231

Tolerance and cross-tolerance with morphine in mice selectively bred for high and low stress-induced analgesia.

I Panocka1, P Marek, B Sadowski.   

Abstract

Mice selectively bred for high (HA) and low (LA) swim-induced analgesia were exposed to two different stress paradigms; one consisting of a 3-min swim at 20 degrees C daily for 14 days, and the other consisting of 3-min swims repeated at 2-h intervals for 48 h. Both forms of chronic stress resulted in the development of tolerance to swim-induced antinociception to a greater degree in the HA mice than in control (C) mice, but were both ineffective at inducing tolerance in LA mice. Swimming repeated at 2-h intervals for 48 h resulted in cross-tolerance with morphine in HA and C mice. Naloxone (1 and 10 mg/kg, IP) failed to antagonize swim-induced analgesia in mice that had experienced chronic swimming in the 2-h/48-h paradigm. The daily swimming paradigm failed to produce cross-tolerance with morphine analgesia in any line. Differential degree of tolerance in three lines supports a hypothesis that selective breeding for high and low stress-induced analgesia has modified the degree of opioid involvement in the endogenous analgesia mechanisms.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1805231     DOI: 10.1016/0091-3057(91)90553-e

Source DB:  PubMed          Journal:  Pharmacol Biochem Behav        ISSN: 0091-3057            Impact factor:   3.533


  2 in total

Review 1.  The genetics of pain and pain inhibition.

Authors:  J S Mogil; W F Sternberg; P Marek; B Sadowski; J K Belknap; J C Liebeskind
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

2.  Mechanisms Underlining Inflammatory Pain Sensitivity in Mice Selected for High and Low Stress-Induced Analgesia-The Role of Endocannabinoids and Microglia.

Authors:  Piotr Poznanski; Joanna Giebultowicz; Justyna Durdzinska; Tomasz Kocki; Mariusz Sacharczuk; Magdalena Bujalska-Zadrozny; Anna Lesniak
Journal:  Int J Mol Sci       Date:  2022-10-02       Impact factor: 6.208

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.